Targeting HIF‐2α in renal cell carcinoma: Expanding upon belzutifan
By expanding upon the foundation established by belzutifan, the field is poised for further therapeutic advances.
Authors
- James Brugarolas (ORCID: https://orcid.org/0000-0002-8575-499X)
- Melanie M. Domenech Rodríguez (ORCID: https://orcid.org/0000-0002-6610-6890)
- Uttam K. Tambar (ORCID: https://orcid.org/0000-0001-5659-5355)
- Qian Qin
Institutions
- The University of Texas Southwestern Medical Center (US)
Publication Details
- Journal
- Cancer
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1002/cncr.70239
- Primary Topic
- Cancer, Hypoxia, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.00